Handmade quality · Free shipping over $75 · Explore the atelier

E-3810 - CAS# 1058137-23-7 04995274 Recent Results Cancer Res

SKU: 46845356435

4.3
USD125.00 USD172.00

Pay in 4 interest-free payments of $31.25 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 29 - Aug 3

Description

Recent Results Cancer Res

Formula: C27H21ClN2O3

InChiKey: LUKBXSAWLPMMSZ-OWOJBTEDSA-N

Vacuolin-1 is a potent and cell-permeable inhibitor that blocks the Ca(2+)-dependent exocytosis of lysosomes and prevents the release of lysosomal content without affecting the process of resealing

Functionalized von-Hippel-Lindau (VHL) protein ligand for PROTAC® research and development

E-3810 - CAS# 1058137-23-7 04995274 Recent Results Cancer ResLucitanib , also known as E 3810 and AL3810, is a novel dual inhibitor targeting human vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs) with antiangiogenic activity. VEGFR FGFR dual kinase inhibitor E 3810 inhibits VEGFR 1, 2, 3 and FGFR 1, 2 kinases in the nM range, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation, and the induction of tumor cell death. Both

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products